Two Distinct Clinical Features and Cognitive Impairment in Amyotrophic Lateral Sclerosis Patients with TARDBP Gene Mutations in the Chinese Population

XiaoDong Ju,WenChao Liu,XiaoGang Li,Na Liu,Nan Zhang,Tao Liu,Min Deng

DOI: https://doi.org/10.1016/j.neurobiolaging.2015.10.032

IF: 5.133

2016-01-01

Neurobiology of Aging

Abstract:Mutations in the TARDBP gene have been identified as a major causative factor in amyotrophic lateral sclerosis (ALS). However, few reports have analyzed the relationship of genotype-phenotype, especially in Chinese ALS patients. Our study investigated the presence and frequency of TARDBP mutations in Chinese patients with ALS. Additionally, we investigated correlations among clinical features and TARDBP gene mutations in a large ALS family with the p.M337 V mutation and one sporadic ALS (SALS) patient with the p.S393 L mutation. The pedigree with the p.M337 V mutation showed variable clinical features with a long lifespan, particularly cognitive impairment. One patient carrying the p.S393 L mutation experienced ALS with cognitive impairment; the patient also had a family history of frontotemporal dementia (FTD). This is the first report of detailed genetic and clinical characterizations of the TARDBP gene in a Chinese population. This research is also the first to demonstrate that the p.M337 V and the p.S393 L mutations are related to cognitive impairment in ALS patients. The mutation frequency of TARDBP was 5.6% in Chinese, SOD1-negative familial ALS (FALS), which was much higher than that reported in previous studies conducted with Caucasian populations, whereas the TARDBP mutation frequency was lower in the Chinese population with regard to SALS patients. Our results emphasize the importance of the genetic and clinical characterization of TARDBP mutations in ALS, which allows us to understand the genotypeephenotype relationship and relative frequencies in different populations. (C) 2016 Elsevier Inc. All rights reserved.